Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN
Rubin Jonathan exercised options for 750 Supernus Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 12, 2026 · Filed Aug 14, 2026
On Aug 12, 2026, Rubin Jonathan (SVP, Chief Medical Officer) exercised options for 750 Supernus Pharmaceuticals, Inc. shares, leaving 13,979 shares. Filed Aug 14, 2026 (Form 4).
- Options exercised
- 750 shares
- Holding after
- 13,979 shares
- Trading plan
- No
- Role
- SVP, Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 750 | 14,342 | Direct | |
| Aug 12, 2026 | Common Stock | Shares withheld for tax | 363 | US$46.57 | 13,979 | Direct |